Class A Credits: 1
Pharmacology Credits: 1
Course Launch Date: 11/17/21
Course Expires: 7/18/22
Dexmedetomidine is especially advantageous as an opioid sparing adjunct in children who are at an increased risk of postoperative respiratory depression, such as those who are obese, have obstructive sleep apnea or underlying respiratory conditions or those presenting with enlarged tonsils and/or adenoids. However, practitioners who do not frequently anesthetize children or are not familiar with the risks and benefits of dexmedetomidine may avoid its use. This presentation includes evidence-based content related to the risks and benefits of the perioperative use of dexmedetomidine in children.
Sugammadex is not FDA approved for patients less than 17 years of age but there is a growing body of evidence related specifically to the use of Sugammadex in children. This presentation includes evidence-based content related to the risks and benefits of Sugammadex in children and includes an overview of its use in special pediatric population groups.
In February 2019, MHAUS released a consensus statement that provides clarification for some current recommendations, revisions to some others and the addition of new best practices. Because these revised guidelines are relatively new, many practitioners are not aware of these current, evidence-based prevention and treatment strategies. This presentation includes a summary of the 2019 clarifications, revisions and additions to the MHAUS guidelines for prevention and treatment of malignant hyperthermia.
Note- This session was recorded during the 2021 Virtual Congress Live Stream Programming. Therefore, you will see committee member introductions and live question and answers.
The American Association of Nurse Anesthetists is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
AANA is an approved provider by the California Board of Registered Nursing, CEP #10862.
Post-Test Attempt Notice
A minimum passing score of 80% is required to pass this course. You have TWO opportunities to achieve a passing score. If you fail to achieve a passing score of 80%, you will not receive CE credit for this course.
The views, information, or opinions expressed within the videos and audio are solely those of the individuals involved and do not necessarily represent those of the American Association of Nurse Anesthetists.
Course content has been prepared by the presenter/developer, and each viewer agrees that the presenter/developer is solely responsible for the content and the accuracy thereof. The viewer agrees that the American Association of Nurse Anesthetists has no responsibility or liability for the accuracy or completeness of the content.
Dr. Herbinger has 40 years of pediatric critical care experience with 25 of those as a CRNA. She completed MSN at Samuel Merritt and a DNP at UAB with a focus on pediatric airway management. In 2017, Dr. Herbinger’s manuscript entitled, Evidence Based Use of Cuffed Endotracheal Tubes in Children, was published in the Journal of PeriAnesthesia Nursing. I have taught full-time at Samford University for six years but continue to practice one day a week at Children’s of Alabama.
This course expires in less than 3 days. You will not be able to access this course past the expiration date. Click OK to add this course to your cart